title: Are there concerns about generic medicines in rheumatology?
authors.affiliation: Service de rhumatologie, Groupe hospitalier Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux, France; Laboratoire de thérapeutique, Université Bordeaux-Segalen, 33076 Bordeaux, France. Electronic address: bernard.bannwarth@u-bordeaux2.fr.
authors.forename: Bernard
authors.initials: B
authors.lastname: Bannwarth
authors.affiliation: Service de rhumatologie, Groupe hospitalier Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Kostine
authors.affiliation: Service de rhumatologie, Groupe hospitalier Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Poursac
mesh_terms: D004345:Drug Industry / Q000331:legislation & jurisprudence; D016568:Drugs, Generic / Q000494:pharmacology / Q000592:standards*; D005060:Europe; D006801:Humans; D007880:Legislation, Drug; D012219:Rheumatology
chemical_list: D016568:Drugs, Generic
keywords: Bioequivalence; Bisphosphonates; Generic drugs; International non-proprietary name (INN); Rheumatology